Zou Q - Search Results

1

TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance.

Ren H, Du P, Ge Z, Jin Y, Ding D, Liu X, Zou Q. Ren H, et al. Among authors: zou q. J Cancer. 2016 May 25;7(9):1074-80. doi: 10.7150/jca.14031. eCollection 2016. J Cancer. 2016. PMID: 27326250 Free PMC article. Review.

2

Total parathyroidectomy combined with partial auto-transplantation for the treatment of secondary hyperparathyroidism.

Zou Q, Wang HY, Zhou J, Lao ZY, Xue J, Li MX, Li HM, Jin YT, Gu Y, Zhang YL. Zou Q, et al. Chin Med J (Engl). 2007 Oct 20;120(20):1777-82. Chin Med J (Engl). 2007. PMID: 18028770

3

aPKC inhibitors might be the sensitizer of chemotherapy and adoptive immunotherapy in the treatment of hASIPa-overexpressed breast cancer.

Jin YT, Ying XX, Hu YH, Zou Q, Wang HY, Xu YH. Jin YT, et al. Among authors: zou q. Oncol Res. 2008;17(2):59-68. doi: 10.3727/096504008784523630. Oncol Res. 2008. PMID: 18543607

4

CD44/cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients.

Cheng Y, Tao L, Xu J, Li Q, Yu J, Jin Y, Chen Q, Xu Z, Zou Q, Liu X. Cheng Y, et al. Among authors: zou q. Mol Carcinog. 2014 Sep;53(9):686-97. doi: 10.1002/mc.22021. Epub 2013 May 16. Mol Carcinog. 2014. PMID: 23681900

5

Evaluating the response of neoadjuvant chemotherapy for treatment of breast cancer: are tumor biomarkers and dynamic contrast enhanced MR images useful predictive tools?

Zhang Z, Zhang W, Jin Y, Wang H, Gu F, Zhou J, Lao Z, Xu Z, Tang F, Zou L, Tang W, Lu R, Zou Q. Zhang Z, et al. Among authors: zou l, zou q. J Thorac Dis. 2014 Jun;6(6):785-94. doi: 10.3978/j.issn.2072-1439.2014.04.28. J Thorac Dis. 2014. PMID: 24977004 Free PMC article.

6

miR-320a is an independent prognostic biomarker for invasive breast cancer.

Yang H, Yu J, Wang L, Ding D, Zhang L, Chu C, Chen Q, Xu Z, Zou Q, Liu X. Yang H, et al. Among authors: zou q. Oncol Lett. 2014 Sep;8(3):1043-1050. doi: 10.3892/ol.2014.2298. Epub 2014 Jun 30. Oncol Lett. 2014. PMID: 25120655 Free PMC article.

7

Association between molecular subtypes and lymph node status in invasive breast cancer.

Si C, Jin Y, Wang H, Zou Q. Si C, et al. Among authors: zou q. Int J Clin Exp Pathol. 2014 Sep 15;7(10):6800-6. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25400761 Free PMC article.

8

CA IX is upregulated in CoCl2-induced hypoxia and associated with cell invasive potential and a poor prognosis of breast cancer.

Chu CY, Jin YT, Zhang W, Yu J, Yang HP, Wang HY, Zhang ZJ, Liu XP, Zou Q. Chu CY, et al. Among authors: zou q. Int J Oncol. 2016 Jan;48(1):271-80. doi: 10.3892/ijo.2015.3253. Epub 2015 Nov 19. Int J Oncol. 2016. PMID: 26648580

9

EGFR/HER2 inhibitors effectively reduce the malignant potential of MDR breast cancer evoked by P-gp substrates in vitro and in vivo.

Jin Y, Zhang W, Wang H, Zhang Z, Chu C, Liu X, Zou Q. Jin Y, et al. Among authors: zou q. Oncol Rep. 2016 Feb;35(2):771-8. doi: 10.3892/or.2015.4444. Epub 2015 Nov 25. Oncol Rep. 2016. PMID: 26718028

10

UCH-L1 involved in regulating the degradation of EGFR and promoting malignant properties in drug-resistant breast cancer.

Jin Y, Zhang W, Xu J, Wang H, Zhang Z, Chu C, Liu X, Zou Q. Jin Y, et al. Among authors: zou q. Int J Clin Exp Pathol. 2015 Oct 1;8(10):12500-8. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26722437 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,923 results

Search Page

Filters